Effectiveness Study of Single Photon Emission Computed Tomography (SPECT) Versus Positron Emission Tomography (PET) Myocardial Perfusion Imaging

Completed · Phase 4

Conditions studied: Coronary Artery Disease

In brief

The purpose of this study is to compare pharmacologic stress myocardial perfusion PET with pharmacologic stress myocardial perfusion SPECT in a near-simultaneous, head-to-head comparison in the same patient. The investigators hypothesize that pharmacologic stress myocardial perfusion PET will prove superior to pharmacologic stress myocardial perfusion SPECT as a first-line diagnostic test for higher-risk patients with known coronary artery disease (CAD) who present with symptoms consistent with possible worsening of their CAD.

Key facts

Study ID

NCT00976053

Run by

Aspire Foundation

People needed

330

Starts

2009-06-01

Expected to finish

2014-10-01

Last updated by the study team

2014-10-31

Who can join

Age: 30 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of coronary artery disease
• New or worsening symptoms
• Out-patients and in-hospital patients

You may not qualify if…

• Creatinine above 2.5 mg%
• PCI within prior 6 months
• Pregnant females
• Cardiomyopathy (LVEF below 40%)
• Significant valvular heart disease
• Body mass index greater than 38

Where it is running

• Saint Luke's Cardiovascular Consultants — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.